Achieve Life Sciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -60.0% | -835.7% | – | – | – | -932.4% | – | – | – | – | – | – | – | -177.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +20.0% | +33.3% | -25.0% | -40.4% | -27.8% | +125.0% | -34.5% | +35.5% | +13.7% | +4.0% | +7.6% | -86.4% | -43.8% | +4.0% | +44.2% | +33.3% | +127.0% | -1.8% | +9.4% | -23.0% | +50.0% | +0.0% | -9.9% | +0.4% | -2.0% | -5.6% | -3.4% | +0.4% | -0.4% | |
| – | – | – | – | – | – | – | – | – | – | – | -23.6% | -100.0% | +118.4% | +68.9% | +85.0% | +83.1% | +30.3% | +36.2% | -39.7% | -29.2% | -78.9% | +145.4% | +40.6% | +7.1% | +70.1% | +49.5% | +5.2% | +54.8% | +64.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +126.9% | +358.6% | -81.0% | +40.6% | +7.1% | +73.3% | +46.8% | – | – | – | |
| – | -127.3% | – | – | – | – | +63.5% | -73.0% | +563.1% | +935.0% | -88.6% | -978.9% | – | – | -149.9% | – | -3,539.8% | – | – | -39.3% | -252.6% | – | – | -129.4% | – | – | -93.6% | -1,084.8% | – | -276.9% | |
| – | +140.0% | -58.3% | -90.0% | -22.7% | +386.7% | +380.9% | -24.1% | -38.0% | -72.0% | +560.9% | +76.9% | -99.8% | +400.0% | +353.3% | +16.2% | +268.4% | -13.1% | -67.6% | +352.4% | -87.6% | +0.0% | +0.0% | +15.2% | -67.9% | +0.0% | -100.0% | – | -100.0% | – | |
| – | -22.0% | – | -91.2% | +424.0% | -291.2% | -69.7% | +11.0% | -2.2% | – | -214.5% | -73.3% | – | -85.2% | -2,752.6% | – | -184.5% | – | -83.5% | -138.7% | – | +19.2% | -140.5% | – | -100.3% | +0.0% | – | – | +102,661.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -85.9% | -74.6% | -66.7% | +1,080.0% | +778.0% | +145.4% | +10.8% | +14.5% | +131.0% | – | – | – | – | +33,573.8% | -99.5% | +24,554.5% | -100.0% | +223,920.0% | -99.9% | -100.0% | – | – | -66.3% | +554.8% | – | – | +63,729.8% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +25.8% | -95.9% | +1,194.7% | +668.7% | +0.0% | +0.0% | +0.0% | -100.1% | -100.0% | – | – | |
| – | -70.0% | +0.0% | -91.7% | +484.5% | +845.2% | +130.8% | +9.3% | +14.6% | +132.8% | -21.6% | -99.1% | -51.2% | +14,236.4% | +173.7% | -99.5% | +24,666.7% | -100.0% | +252,370.0% | -30.3% | -100.0% | – | +887.4% | -12.3% | +88.6% | +12.0% | -47.2% | -20.9% | +217.6% | +6.2% | |
| – | -225.0% | – | -41.7% | +14.6% | -254.7% | – | – | -197.1% | – | -127.7% | – | – | +1,719.3% | -170.8% | – | -309.5% | – | – | -51.8% | -397.5% | – | -27.6% | +78.3% | +168.4% | -62.6% | -354.6% | – | – | – | |
| – | -93.3% | -5,500.0% | – | – | – | -1,165.3% | – | – | – | – | – | – | – | -177.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.